Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 15/20 | 0.86 |
| ▸ | CA12 | O43570 | 1/20 | 0.74 |
| ▸ | CA2 | P00918 | 1/20 | 0.74 |
| ▸ | CA9 | Q16790 | 1/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7094852 | 0.96 | ALDH1A1 (0.79) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL7095731 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL7097551 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL7095949 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL7093365 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL7095193 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL7092896 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL11808676 | 0.93 | ALDH1A1 (0.75) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL812683 | 0.93 | ALDH1A1 (0.75) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL5567042 | 0.91 | ALDH1A1 (0.75) | ALDH1A1CA12CA2CA9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10301258-B2 | Benzende sulfonamide derivatives as HIV integrase inhibitors | HOWARD UNIVERSITY (US) | 2019-05-28 | — | — | US | claimed |
| US-4929530-A | OXIDATIVE LEUCO DYES, PHOTO-OXIDIZERS, REDUCING AGENTS, ORGANIC SULFONAMIDES AND PHENOLIC COMPONENTS; EXPOSING TO LIGHT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-29 | — | — | US | claimed |
| CN-116970187-B | Preparation method of carboxyl cellulose composite hydrogel containing nitrogen crown ether | 常熟威怡科技有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-116970187-A | Preparation method of carboxyl cellulose composite hydrogel containing nitrogen crown ether | 常熟威怡科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230288610-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-20230288610-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| EP-4225447-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022076625-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |
| US-10301258-B2 | Benzende sulfonamide derivatives as HIV integrase inhibitors | HOWARD UNIVERSITY (US) | 2019-05-28 | — | — | US | disclosed |
| US-10301258-B2 | Benzende sulfonamide derivatives as HIV integrase inhibitors | HOWARD UNIVERSITY (US) | 2019-05-28 | — | — | US | disclosed |
| US-9726932-B2 | Optical film, optical compensation film, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2017-08-08 | — | — | US | disclosed |
| US-6319956-B1 | N1, N4-BIS(CYCLOPROPYLMETHYLAMINO)TRIALKYLENETETRAMINES THAT MAY BE TOLUENESULFONATED. | RIKEN (JP) | 2001-11-20 | — | — | US | disclosed |
| US-5399455-A | Electrophotographic toner composition and image fixing process | FUJI XEROX CO., LTD. (JP) | 1995-03-21 | — | — | US | disclosed |
| US-4929530-A | OXIDATIVE LEUCO DYES, PHOTO-OXIDIZERS, REDUCING AGENTS, ORGANIC SULFONAMIDES AND PHENOLIC COMPONENTS; EXPOSING TO LIGHT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-29 | — | — | US | disclosed |
| US-4824721-A | CAPSULES OF OIL SOLUBLE DYES WHICH SWELL AND RELEASE DYE UPON HEATING | FUJI PHOTO FILM CO., LTD. (JP) | 1989-04-25 | — | — | US | disclosed |
| US-4758495-A | Diazo microcapsule recording material prepared using ion exchange treatment | FUJI PHOTO FILM CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4749679-A | Heat sensitive recording materials | FUJI PHOTO FILM CO., LTD. (JP) | 1988-06-07 | — | — | US | disclosed |
| EP-0262953-A2 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-06 | — | — | EP | disclosed |
| US-4682194-A | MICROCAPSULES CONTAINING LEUCO DYE | FUJI PHOTO FILM CO., LTD. (JP) | 1987-07-21 | — | — | US | disclosed |
| US-4644376-A | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1987-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301258-B2 | Benzende sulfonamide derivatives as HIV integrase inhibitors | NR2E3, NR2E1, PIM3 | ALDH1A1 2073/4885CA12 3817/4885CA2 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.